FAQ

SKI 306X

Known as: SKI306X 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2016
01220042016

Related topics

Related topics

1 relation

Broader (1)

Drugs, Chinese Herbal

Related mentions per year

Related mentions per year

2004-2018
20002005201020152020
SKI 306X
Drugs, Chinese Herbal

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Efficacy of JOINS on Cartilage Protection in Knee Osteoarthritis: Prospective Randomized Controlled Trial
Purpose In this study, we compared the clinical efficacy of JOINS (SKI306X, SK Chemicals) with placebo on cartilage protection… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2016
2016
Prospective, randomized, double-blinded, double-dummy and multicenter phase IV clinical study comparing the efficacy and safety of PG201 (Layla) and SKI306X in patients with osteoarthritis.
ETHNOPHARMACOLOGICAL RELEVANCE This prospective, randomized, double-blinded, double-dummy, multicenter study compared the… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2014
2014
SKI306X inhibition of glycosaminoglycan degradation in human cartilage involves down-regulation of cytokine-induced catabolic genes
BACKGROUND/AIMS SKI306X, a mixed extract of three herbs, Clematis mandshurica (CM), Prunella vulgaris (PV), and Trichosanthes… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
The multicomponent phytopharmaceutical SKI306X inhibits in vitro cartilage degradation and the production of inflammatory mediators.
Clinical studies have demonstrated that SKI306X, a purified preparation of three medicinal plants, relieves joint pain and… (More)
Is this relevant?
2007
2007
Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase…
BACKGROUND SKI306X, which consists of biologically active ingredients from Clematis mandsburica, Tricbosantbes kirilowii, and… (More)
Is this relevant?
2005
2005
SKI306X suppresses cartilage destruction and inhibits the production of matrix metalloproteinase in rabbit joint cartilage explant culture.
SKI306X was previously found to have cartilage protective effects in the experimental osteoarthritis (OA) model. To investigate… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2005
2005
SKI306X, an oriental herbal mixture, suppresses gastric leukotriene B4 synthesis without causing mucosal injury and the diclofenac-induced gastric lesions.
SKI306X compound is a herbal mixture. This plant was in oriental medicine and was clinically approved for the treatment of… (More)
Is this relevant?
2005
2005
Effects of SKI306X on arachidonate metabolism and other inflammatory mediators.
SKI306X was previously reported to have good anti-inflammatory and analgesic efficacy in various studies. To determine its mode… (More)
Is this relevant?
2005
2005
Biol. Pharm. Bull. 28(9) 1615—1620 (2005)
toid arthritis (RA) are the most common inflammatory diseases. Inasmuch as OA and RA afflict more than 80% of all patients… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2004
2004
A four-week, randomized, double-blind trial of the efficacy and safety of SKI306X: a herbal anti-arthritic agent versus diclofenac in osteoarthritis of the knee.
The efficacy and safety of SKI306X, an herbal anti-arthritic agent, was compared with that of diclofenac sodium for the treatment… (More)
  • table I
  • table II
  • table III
  • table I
Is this relevant?